Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.18
Delayed Data
As of 4:14pm ET
 -0.02 / -0.32%
Today’s Change
1.53
Today|||52-Week Range
8.84
+202.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues13.8M28.5M39.0M8.5M
 
 
 
 
 
Depreciation And Amortization--1.5M1.4M1.4M
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses42.2M39.5M42.7M38.2M
 
 
 
 
 
Other Operating Expenses301.0K0.000.000.00
 
 
Research And Development33.7M32.9M35.3M31.7M
 
 
 
 
 
Total Operating Expenses8.5M41.0M44.2M39.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.6M-12.5M-5.1M-31.1M
 
 
 
 
 
Extraordinary Charge---386.0K---22.2M
 
 
 
Interest Expense On Debt4.7M4.7M4.6M4.1M
 
 
 
 
 
Other Expenses-758.0K134.0K751.0K480.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.2M-17.3M-8.9M-56.7M
 
 
 
 
 
Net Income-34.2M-17.3M-8.9M-56.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.1M87.2M87.2M93.0M
 
 
 
 
 
Shares To Calculate EPS Diluted87.1M87.2M87.2M93.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.20-$0.10-$0.61
 
 
 
 
 
EPS Diluted-$0.39-$0.20-$0.10-$0.61